Navigation Links
Geisinger Launches Extensive Study on Obesity and Related Liver Problem

Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study// of one of the fastest growing liver problems.

Nonalcoholic fatty liver disease starts with the accumulation of fat on the liver, which leads to inflammation and scarring. It can progress to the point of permanent liver damage and lead to the potentially fatal cirrhosis. If the damage becomes too great, a liver transplant may be needed. Linked to America's increasing obesity problem, doctors have predicted a steep increase in the coming years.

The disease is asymptomatic in its early stages and many people don't know they have it initially. Geisinger Health System is leveraging several key system resources in an effort to develop a simple blood test to diagnose the disease. Early detection would likely help patients better manage the disease and could even save lives. Yet a major obstacle needs to be cleared first.

Right now, the only way to definitely diagnose the disease is through a liver biopsy, where a needle is inserted into the skin and liver tissue is collected. However, biopsies can pose health risks because of the potential for bleeding from the liver or for infection.

The goal is to develop a noninvasive blood test for the disease and then bring it to market so other physicians can use it, said Geisinger staff scientist Glenn S. Gerhard, MD.

To that end, Geisinger is uniquely positioned to develop such a test because of the array of resources the system has at its disposal.

Geisinger has collected more than 600 liver tissue and blood samples donated from patients who have undergone bariatric weight loss surgery. That work has been made possible through collaboration among Geisinger researchers, clinicians and surgeons.

Thanks to the very high participation rate of patients, the size of Geisinger's liver tissue and
'"/>




Page: 1 2

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Serum Institute Launches New Tetanus-Diphtheria Vaccine
3. Scottish Health Minister Launches Organ Donor Plan
4. Pfizer Launches Viagra For Lung Disease In UK
5. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
6. PM Launches Healthcare Foundation For India
7. African Union Launches A Programme On Acceleration of HIV Prevention
8. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
9. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
10. The British Medical Journal Launches A Health Website
11. APEC Launches Bird Flu Exercise

Post Your Comments:
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 ...us may have peaked in late October, but the pandem... illness in all age groups, including the elderly,...corporated (NYSE: DGX ), the world,s leading pro...ces. ,, In its most recent Quest Diagnostics H...
(Date:11/20/2009)..., ST. LOUIS, Nov. 20 C...that it will present at the Bank of America Merril...r 2-3, 2009, at the Crowne Plaza Hotel Times Squar...nesday, December 2nd at 8:30 a.m. Eastern Time. In...live, audio webcast of Centene,s presentation at: ...
(Date:11/20/2009)...INSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNewswire... mission to redefine what it means to be "happy" d...nselor with a specialty in family counseling and c...t University, Gladding says research shows that it...adness and even depression during the holidays. ,...
(Date:11/20/2009)..., NEW YORK, Nov. 20 SI...hat it will broadcast Doctor Radio Reports: Wha...in-depth special hosted by veteran journalist Perr...-bin/prnh/20080819/NYTU044LOGO ) ,, Doctor Ra... Mammograms will air November 21 live at 10:00 ...
(Date:11/20/2009)...ions of exposure to formaldehyde used for embalmin...increased risk of death from myeloid leukemia, acc... in the Journal of the National Cancer Institute ... from lymphohematopoietic malignancies and brain c...ustry workers, all of whom may have worked with fo...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
...The most deadly form of skin cancer , advanced mel... patients with tumor proteins, say researchers acc...d what effect vaccinating patients with tumor anti...gens increased the amount of killer T-cells that c...
...A new discovery could help prevent complications f...s preeclampsia. Preeclampsia typically develops af...d by high blood pressure, // edema, and protein i...complications and forces premature delivery of the...
...Natural killer cells are part of the body’s immune...n and some cancers, particularly leukemia. A new s...us leukemia // patients may lie in artificially s... the bone marrow that has become resistant to stan...
...Researchers say they have found that stem cell the...cks . During the study injecting stem cells from o...other pig's damaged heart muscle restored the hear...rapy. They found injecting "adult" stem cells dire...
...Epilepsy is a disorder caused by abnormal surges i... in seizures and is found to affect more than 2 mi...th epilepsy can live seizure-free by just taking m...those with temporal lobe epilepsy, the most common...
...A drug commonly used to prevent bone loss may also...w study indicates oral sodium // clodronate may sl... risk of death. This is a drug commonly used to pr...ven hormone therapy for bone metastases. The patie...
Other Medicine News:
(Date:11/19/2009)... , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-Firs... BCRX ) today announced the pricing of a public of...$9.75 per share, resulting in gross proceeds of $4... by BioCryst pursuant to an effective shelf regist...ies and Exchange Commission. BioCryst has also gr...
(Date:11/19/2009)... , LOVELAND, Colo., Nov. 19 /PRNewswire-First... its customers, experience, Heska Corporation (Nas...today the launch of its new and improved website. ... of analysis, design and programming to align the ...gic objectives. ,, (Logo: http://www.newscom...
(Date:11/19/2009)... , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-F... ALXA ) announced today that its corporate presen... Piper Jaffray Health Care Conference on Wednesday... presentation will be webcast from The New York Pa...omas B. King, Alexza President and CEO. ,, To...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Designer molecules being developed to fight disease 12603 1Designer molecules being developed to fight disease 12603 2Protest 3A AHF to Renew Call for California Condoms in Porn Law at Larry Flynts Hustler Hollywood Store 48810 1Protest 3A AHF to Renew Call for California Condoms in Porn Law at Larry Flynts Hustler Hollywood Store 48810 2Endologix Receives Nasdaq Letter on Director Independence 48808 1Endologix Receives Nasdaq Letter on Director Independence 48808 2
...nts, Wake After Sleep Onset and Total,Sleep Time, ...Persistent Sleep, were met at both doses - Evotec ... 10am EST) today , HAMBURG, Germany | OXFORD, Engl...hange: EVT) announced today positive top-line,resu...201 in,patients with chronic primary insomnia. EVT...
...ted at ASCO with cediranib - a selective,VEGF sign... alive,and progression- free at six months(1), CHI...nvestigational agent cediranib (AZD2171) were pres...Society of Clinical Oncology,(ASCO) from a study i...nvasive form of brain tumor with a high unmet medi...
Other Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 4
...on the solid, tested XiIIIPlus platform, the R170X...evel of on-demand printing flexibility in tag plac...eamless integration into enterprise systems, autom...iple power levels, statistics tracking, easier RFI...
...on the solid, tested XiIIIPlus platform, the R110X...vel of on-demand printing flexibility in tag place...amless integration into enterprise systems, automa...ple power levels, statistics tracking, easier RFID...
Zebra 90xiIII Printers
Zebra 105SL Cutting Edge Barcode Printer Network Connectivity
Medicine Products: